| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000007748 |
| Receipt No. | R000009114 |
| Official scientific title of the study | The examination of the relations with sleep disturbance and the prognosis for the bipolar disorder |
| Date of disclosure of the study information | 2013/03/31 |
| Last modified on | 2017/04/17 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | The examination of the relations with sleep disturbance and the prognosis for the bipolar disorder | |
| Title of the study (Brief title) | The examination of the relations with sleep disturbance and the prognosis for the bipolar disorder | |
| Region |
|
|
| Condition | ||
| Condition | The insomnia patients with bipolar disorder diagnosised by DSM, and more 6 points of Pittsburgh Sleep Quality Index | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | YES | |
| Objectives | |
| Narrative objectives1 | We divide treatment for the sleep disturbance of the bipolar disorder into olanzapine, aripiprazole, flunitrazepam, We compared three groups of correlation to the degree of improvement of the sleep disturbance and remission of the bipolar disorder. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Young Mania Rating Scale
Pittsburgh Sleep Quality Index Hamillton Depression Scale |
| Key secondary outcomes | sleep scan
clock gene RNA expression |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -but assessor(s) are blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | YES |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | Numbered container method |
| Intervention | ||
| No. of arms | 3 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Olanzapine medication group | |
| Interventions/Control_2 | Aripiprazole medication group | |
| Interventions/Control_3 | Flunitrazepam medication group | |
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The patients of bipolar disorder diagnoded by DSM, and who had the insomnia with more 6 points of Pittsburgh Sleep Quality Index. | |||
| Key exclusion criteria | The patients with a history of hypersensitivity for olanzapine, aripiprazole,flunitrazepam.
The patients with serious hepatic disorder. The patients with diabetes, the patients with a history of diabetes. The patients with acute narrow-angle glaucoma. The patients with myasthenia gravis. The women with during the pregnancy or the possibility to pregnancy. |
|||
| Target sample size | 60 | |||
| Research contact person | |
| Name of lead principal investigator | Kenichi Osada |
| Organization | St. Marianna University School Of Medicine |
| Division name | Neuropsychiatry |
| Address | 2-16-1 Sugao, Miyamae-ku, Kawasaki |
| TEL | 044-977-8111 |
| k2osada@marianna-u.ac.jp | |
| Public contact | |
| Name of contact person | Kenichi Osada |
| Organization | St. Marianna University School Of Medicine |
| Division name | Neuropsychiatry |
| Address | 2-16-1 Sugao, Miyamae-ku, Kawasaki |
| TEL | 044-977-8111 |
| Homepage URL | |
| k2osada@marianna-u.ac.jp | |
| Sponsor | |
| Institute | St. Marianna University School Of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000009114 |